Non-Mammalian Models for Mitochondria Research in CNS Disorders
Biomolecules · 22.07.2026 · 16 (7) · 1072
DOI: 10.3390/biom16071072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.07.2026. Verfasst von Dubravka Svob Strac und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ruđer Bošković Institute, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Mitochondria, Central Nervous System Diseases. Die Arbeit nennt 302 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mitochondrial dysfunction is increasingly recognized as a major contributor to central nervous system (CNS) disorders, including neurodegenerative and neuropsychiatric diseases. Animal models are essential for elucidating disease mechanisms and supporting the development of new therapeutic strategies. Among these models, non-mammalian organisms offer distinct advantages, including low cost, rapid life cycles, genetic tractability, and suitability for large-scale, high-throughput studies. Organisms such as Saccharomyces cerevisiae, Dictyostelium discoideum, Caenorhabditis elegans, Drosophila melanogaster, and Danio rerio have substantially advanced the understanding of mitochondrial processes relevant to CNS pathology. Studies using these models have revealed conserved mechanisms involving mitophagy, mitochondrial quality control, respiratory function, bioenergetic signaling, and neurodegenerative pathways. Their strengths, including scalability, live imaging capacity, and efficient genetic manipulation, have accelerated disease modeling and therapeutic discovery. However, simplified physiology, evolutionary distance from humans, and the incomplete representation of complex CNS organization limit their translational relevance and often require validation in higher-order organisms. Nevertheless, integrating these models into CNS research, particularly alongside emerging technologies, provides a powerful strategy for linking fundamental mitochondrial biology with translational neuroscience. This review summarizes the use of non-mammalian models in neuroscience research, with an emphasis on mitochondrial dysfunction in CNS disorders and their potential to support future therapeutic advances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ruđer Bošković Institute, 10000 Zagreb, Croatia.
- Faculty of Biotechnology and Drug Development, 51000 Rijeka, Croatia.
- Division of Toxicology, Institute for Medical Research and Occupational Health, 10000 Zagreb, Croatia.
- Department of Psychology, Algebra Bernays University, 10000 Zagreb, Croatia.
ORCID-Profile: Dubravka Svob Strac, Vedrana Filic, Ivana Vrhovac Madunic, Josip Madunic, Ana Cipak Gasparovic, Rozi Andretic Waldowski
Zitieren
APA
Svob Strac, D., Filic, V., Filosevic Vujnovic, A., Vrhovac Madunic, I., Madunic, J., Cipak Gasparovic, A., Havelka Mestrovic, A., & Andretic Waldowski, R. (2026). Non-Mammalian Models for Mitochondria Research in CNS Disorders. Biomolecules, 16(7), 1072. https://doi.org/10.3390/biom16071072
Vancouver
Svob Strac D, Filic V, Filosevic Vujnovic A, Vrhovac Madunic I, Madunic J, Cipak Gasparovic A, et al. Non-Mammalian Models for Mitochondria Research in CNS Disorders. Biomolecules. 2026;16(7):1072. doi:10.3390/biom16071072
BibTeX
@article{SvobStrac2026,
author = {Svob Strac, Dubravka and Filic, Vedrana and Filosevic Vujnovic, Ana and Vrhovac Madunic, Ivana and Madunic, Josip and Cipak Gasparovic, Ana and Havelka Mestrovic, Ana and Andretic Waldowski, Rozi},
title = {Non-Mammalian Models for Mitochondria Research in CNS Disorders},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {7},
pages = {1072},
doi = {10.3390/biom16071072}
}
EUVIMED